ArticleActa dermato-venereologica2022

Ruxolitinib, a JAK1/2 Inhibitor as Treatment for Paraneoplastic Pemphigus: A Case Report.

Birao Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.